AI-generated summary
The authors studied 50 patients with melasma treated with a 1,064-nm Q-switched Nd:YAG laser weekly for nine sessions. They report a 61.3% average decrease in MASI scores and a 35.8% drop in melanin index, with 64% recurrence at three months. The authors also note minimal adverse events and that the outcome depended on baseline disease severity.
- Participants
- 50
- Who or what was studied
- Patients with melasma (47 female, 3 male); the abstract notes melasma is more common in Fitzpatrick skin types IV to VI
- Limits stated in the abstract
- The abstract reports a high recurrence rate of 64% at three-month follow-up and states that further adjunctive therapy needs to be explored.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ovid.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Melanin. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.